Business Wire8h
Reprieve Cardiovascular Builds Clinical Momentum with Positive Results from FASTR Pilot Trial and FDA Investigational Device Exemption Approval for Pivotal Trial
Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...
Daijiworld18h
Study shows potassium-enriched salt can reduce recurrent stroke risk
Potassium supplements in salt can significantly reduce the risks of stroke recurrence as well as death, according to an international study. The study comes amidst the new recommendation by the World ...